Omicron subvariant XBB.1.5 accounts for nearly half of U.S. Covid cases - CDC | Inquirer
 
 
 
 
 
 

Omicron subvariant XBB.1.5 accounts for nearly half of U.S. Covid cases – CDC

/ 11:28 AM January 20, 2023

Test tube labeled "COVID-19 Omicron variant test positive" is seen in this illustration picture taken January 15, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

Test tube labeled “COVID-19 Omicron variant test positive” is seen in this illustration picture taken January 15, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

The fast-spreading Omicron subvariant XBB.1.5 accounted for nearly half of the COVID-19 cases in the United States, data from the U.S. Centers for Disease Control and Prevention showed on Friday.

It is estimated to have accounted for 49.1% of COVID cases in the country in the week ended Jan. 21, compared with 37.2% estimated last week.

XBB.1.5 is currently the most transmissible variant. It is an offshoot of XBB, a combination of two other Omicron sub-variants, which was first detected in October.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

WHO Director General Tedros Adhanom Ghebreyesus tweeted a few weeks ago that XBB.1.5 has been on the rise globally and identified in over 25 countries.

It is unclear if XBB.1.5 can cause its own wave of global infections, but experts say the current booster shots continue to protect against severe symptoms, hospitalization and death

Want stories like this delivered straight to your inbox? Stay informed. Stay ahead. Subscribe to InqMORNING

Don't miss out on the latest news and information.
TAGS: COVID-19
For feedback, complaints, or inquiries, contact us.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.




This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.